Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Eileen Francis
Bayer consumer readies 19-product pipeline for 2017 as it works to increase sales of brands including Coppertone and Dr. Scholl’s brands that have been sluggish since being acquired from Merck & Co.
Nutraceutical Wellness will modify claims for Nutrafol Hair Re-Growth Supplement after ERSP finds two should be narrowed to clarify that ingredients and not the product were tested and that external factors impact hair health.
Ultra Botanica’s supporting research relied on human studies with one to three participants and mice studies without direct comparisons to competing products.
FDA sends warning letters to Life Extensions Foundation Buyers Club and Humaworm for claims their products could treat or cure various diseases.
CRN argues that legislation a New York state assembly member authored to ban sales of supplements to consumers younger than 18 would restrict the sale of the supplements to all consumers.
GlaxoSmithKline Flonase Sensimist Allergy Relief could help fend off private label competition in the intranasal corticosteroid category, the firm says. Despite a 19% drop in sales of the original Flonase OTC in the fourth quarter, US consumer health care sales grew 5% to $2.2bn on a reported basis in 2016.